A carregar...
(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments
In life-threatening conditions such as cancer and rare diseases, where there is no cure and no U.S. Food and Drug Administration (FDA)-approved therapy, patients sometimes seek access to an unapproved, experimental therapy through expanded access programs as their last, best hope for treatment to sa...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772317/ https://ncbi.nlm.nih.gov/pubmed/26926908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0586-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|